Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Retinal Cases & Brief Reports|October 24, 2023
RETRACTION OF CYSTOID MACULAR EDEMA FROM THE FOVEA AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR BIRDSHOT CHORIORETINOPATHYShakoor Ba-Ali, Josefine Fuchs, Michael Larsen
Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 24, 2004
Oculometric characteristics of extreme hypermetropia in two faroese familiesHans Callø Fledelius, Helle Josefine Fuchs, Thomas Rosenberg
Acta Ophthalmologica Scandinavica|April 16, 2002
Uveal effusion and ultrasonic imaging: a clinical seriesHans C Fledelius, Helle Josefine Fuchs, Peter Koch Jensen, et al.
Ophthalmic Genetics|April 13, 2005
Hereditary high hypermetropia in the Faroe IslandsJosefine Fuchs, Kári Holm, Kaj Vilhelmsen, et al.
Parasite Epidemiology and Control|January 10, 2022
The disease burden of ocular toxoplasmosis in Denmark in 2019: Estimates based on laboratory testing of ocular samples and on publicly available register dataJonathan Marstrand, Jørgen Anders Lindholm Kurtzhals, Helle Josefine Fuchs, et al.
Acta Ophthalmologica|September 27, 2015
Morphological features in eyes with endophthalmitis after cataract surgery - histopathology and optical coherence tomography assessmentSøren Solborg Bjerrum, Jan Ulrik Prause, Josefine Fuchs, et al.
Acta Ophthalmologica|November 19, 2014
Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital settingPascal W Hasler, Sara Brandi Bloch, Jørgen Villumsen, et al.
Acta Ophthalmologica|June 16, 2015
Visual outcomes in relation to time to treatment in neovascular age-related macular degenerationAnnette Rasmussen, Sara Brandi, Josefine Fuchs, et al.
American Journal of Ophthalmology Case Reports|March 6, 2018
Retinitis pigmentosa associated with a mutation in BEST1Lauren A Dalvin, Jackson E Abou Chehade, John Chiang, et al.
Acta Ophthalmologica|August 19, 2016
Neovascular age-related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injectionsAnnette Rasmussen, Birgit Sander, Michael Larsen, et al.
Pageof 2